Concepedia
Statistics
Publications
28
Citations
814
H-Index
17
Active since
2008
Affiliations
University of Antwerp(Current)
Antwerp University Hospital
Ghent University Hospital
Molecular Targeting Technologies (United States)
University of Groningen
Christel Vangestel is an author at University of Antwerp specializing in medicine, oncology, and pharmacology.
Top concepts
MedicineOncologyPharmacologyTumor BiologyCancer ResearchPathologyEngineeringCell BiologyCancer TherapyDrug Discovery
Publications per year
2008–2023
Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelators
Euy Sung Moon, Filipe Elvas, Gwendolyn Vliegen et al. · EJNMMI Radiopharmacy and Chemistry · 2020 · 107 citations · Full text
Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors
Timon Vandamme, Matthias Beyens, Ken Op de Beeck et al. · British Journal of Cancer · 2016 · 73 citations · Full text
ATG4B inhibitors with a benzotropolone core structure block autophagy and augment efficiency of chemotherapy in mice
Ammar Kurdi, Matthias Cleenewerck, Christel Vangestel et al. · Biochemical Pharmacology · 2017 · 69 citations
Cell Autophagy, Mitophagy, Medicine +10
Characterization of [99mTc]Duramycin as a SPECT Imaging Agent for Early Assessment of Tumor Apoptosis
Filipe Elvas, Christel Vangestel, Sara Rapic et al. · Molecular Imaging and Biology · 2015 · 51 citations · Full text
<sup>99m</sup>Tc-Duramycin SPECT Imaging of Early Tumor Response to Targeted Therapy: A Comparison with<sup>18</sup>F-FDG PET
Filipe Elvas, Jan Boddaert, Christel Vangestel et al. · Journal of Nuclear Medicine · 2016 · 49 citations · Full text
1–5 of 28